FDA Expands Darzalex Faspro Indication in Myeloma

The combination was approved for induction and consolidation in transplant-eligible patients with newly diagnosed multiple myeloma.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-expands-darzalex-faspro-indication-myeloma-2024a1000e30?src=rss